Contrast Media Reference
You can sort and view the chart below by cicking one of the fields.
IFU (PDF)Contrast Agent Ionic/Nonionic Osmotic Concentration Manufacturer Carotid LCA RCA LV Aorta Celiac Renal Mesenteric Iliac Femoral Viscosity (cPs) Half Life Remarks
Cholografin lodipamideIoniclow osmolarBracco Diagnostics Not 4 ♥.Not 4 ♥.Not 4 ♥.        * visualization of the gallbladder and biliary ducts in the differential diagnosis of acute abdominal conditions * visualization of the biliary ducts, especially in patients with symptoms after cholecystectomy * visualization of the gallbladder in patients unable to take oral contrast media or to absorb contrast media from the gastrointestinal tract.
Conray 30 IothalamateIoniclow osmolarMallinckrodt3-10 mlNot 4 ♥.Not 4 ♥.Not 4 ♥.15-30 ml     1.590 min.* Intravenous infusion urography, contrast enhancement of computed tomographic brain images and arterial digital subtraction angiography.
Conray 43 IothalamateIoniclow osmolarMallinckrodt3-10 mlNot 4 ♥.Not 4 ♥.Not 4 ♥.15-30 ml     2.090 min.* lower extremity venography, intravenous infusion urography, contrast enhancement of computed tomographic brain images and arterial digital subtraction angiography.
Conray IothalamateIoniclow osmolarMallinckrodt Not 4 ♥.Not 4 ♥.Not 4 ♥.      4.090 min.* excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, in travenous digital subtraction angiography and arterial digital subtraction angiography.
Eovist Gadoxetate low osmolarBayer HealthCare Not 4 ♥.Not 4 ♥.Not 4 ♥.      1.190.95 hr. 
Hexabrix IoxaglateIoniclow osmolarGuerbet6-10 ml8 ml5 ml45 ml25-50 ml40 ml 20-40 ml40 ml30 ml7.592 min. 
Isovue 200 IopamidolNon Ioniclow osmolarBracco Diagnostics Not 4 ♥.Not 4 ♥.Not 4 ♥.      2.02 hrs.Peripheral Venography (not to exceeded 350 mL)
Isovue 250 IopamidolNon Ioniclow osmolarBracco Diagnostics Not 4 ♥.Not 4 ♥.Not 4 ♥.      3.02 hrs.Excretory Urography
Isovue 300 IopamidolNon Ioniclow osmolarBracco Diagnostics8-12 mlNot 4 ♥.Not 4 ♥.Not 4 ♥.25-50 ml   25-50 ml5-40 ml4.72 hrs.Cerebral Arteriography Excretory Urography
Isovue 370 IopamidolNon Ioniclow osmolarBracco Diagnostics8-12 ml2-10 ml2-10 ml25-50 ml25-50 ml50 ml10 ml 25-50 ml5-40 ml9.42 hrs.The elimination serum or plasma half-life is approximately two hours; the half-life is not dose dependent. No significant metabolism, deiodination, or biotransformation occurs.
Lipiodol Ethiodol  Guerbet Not 4 ♥.Not 4 ♥.Not 4 ♥.        *In diagnostic radiology Lymphography: intralymphatic injection only Diagnosis of liver lesions: selective intra-arterial injection only *In interventional radiology Embolization with surgical glues: selective intra-arterial injection only *In iodine deficiency Intramuscular injection only
Magnevist GadopentetateIonic Bayer HealthCare Not 4 ♥.Not 4 ♥.Not 4 ♥.      2.91.6 hrsFor use with magnetic resonance imaging (MRI) in adults, and pediatric patients (2 years of age and older) to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues, in the head and neck, and in the body (excluding the heart). Upon injection, the meglumine salt is completely dissociated from the gadopentetate dimeglumine complex. Gadopentetate is exclusively eliminated in the urine with 83 ± 14% (mean ± SD) of the dose excreted within 6 hours and 91 ± 13% (mean ± SD) by 24 hours, post-injection.
MD 76 DiatrizoateIonichigh osmolarMallinckrodt 4-10 ml4-10 ml35-50 ml  5-10 ml  20-40 ml10.5100 min.* excretion urography, aortography, pediatric angiocardiography, peripheral arteriography, selective renal arteriography, selective visceral arteriography, selective coronary arteriography with or without left ventriculography, contrast enhancement of computed tomographic brain imaging and for intravenous digital subtraction angiography.
MultiHance GadobenateIonic Bracco Diagnostics Not 4 ♥.Not 4 ♥.Not 4 ♥.      5.3 For intravenous use in magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults and children over 2 years of age to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues and use in magnetic resonance angiography (MRA) to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive vascular disease.
Omnipaque 140 IohexolNon Ioniclow osmolarGE Healthcare Not 4 ♥.Not 4 ♥.Not 4 ♥.      1.5 Cerebral, neck, abdominal, renal and peripheral vessels
Omnipaque 180 IohexolNon Ioniclow osmolarGE Healthcare Not 4 ♥.Not 4 ♥.Not 4 ♥.      2.0 Intrathecal administration
Omnipaque 240 IohexolNon Ioniclow osmolarGE Healthcare Not 4 ♥.Not 4 ♥.Not 4 ♥.      2.4 Intrathecal administration Cerebral, neck, abdominal, renal and peripheral vessels *Venography (per leg): 20 mL to 150 mL of OMNIPAQUE 240 (240 mgI/mL)
Omnipaque 300 IohexolNon Ioniclow osmolarGE Healthcare Not 4 ♥.Not 4 ♥.Not 4 ♥.50-80 ml30-60 ml5-15 ml30-60 ml8-25 ml9-20 ml6.3 Intrathecal administration *Aortofemoral runoffs: 30 mL to 90 mL of OMNIPAQUE 300 (300 mgI/mL) *Selective arteriograms (femoral/iliac): 10 mL to 60 mL of OMNIPAQUE 300 (300 mgI/mL) *Venography (per leg): 40 mL to 100 mL of OMNIPAQUE 300 (300 mgI/mL)
Omnipaque 350 IohexolNon Ioniclow osmolarGE Healthcare6-12 ml5 ml5 ml40 ml50-80 ml30-60 ml5-15 ml30-60 ml8-25 ml9-20 ml10.4 *Aortofemoral runoffs: 20 mL to 70 mL of OMNIPAQUE 350 (350 mgI/mL) *Selective arteriograms (femoral/iliac): 10 mL to 30 mL of OMNIPAQUE 350 (350 mgI/mL)
Omniscan GadodiamideNon Ionic GE Healthcare Not 4 ♥.Not 4 ♥.Not 4 ♥.        Gadolinium-based contrast agent for diagnostic magnetic resonance imaging (MRI) indicated for intravenous use to: • Visualize lesions with abnormal vascularity in the brain, spine, and associated tissues • Facilitate the visualization of lesions with abnormal vascularity within the thoracic, abdominal, pelvic cavities, and the retroperitoneal spac
Optimark GadoversetamideNon Ionic Mallinckrodt Not 4 ♥.Not 4 ♥.Not 4 ♥.        For use with magnetic resonance imaging (MRI) in patients with abnormal blood brain barrier or abnormal vascularity of the brain, spine and associated tissues, and abnormal vascularity in the liver in patients who are highly suspect for liver structural abnormalities on computed tomography.
Optiray 240 IoversolNon Ioniclow osmolarMallinckrodt          3.0 * Optiray 240: 3.0 cPs (Cerebral Angiography and Venography)
Optiray 300 IoversolNon Ioniclow osmolarMallinckrodt          5.5 * Optiray 300: 5.5 cPs (Cerebral and Peripheral Angiography)
Optiray 320 IoversolNon Ioniclow osmolarMallinckrodt 8 ml6 ml40 ml45 ml45 ml9 ml4 ml60 ml40 ml5.8 Optiray 320: 5.8 cPs (Cardiac Angiography)
Optiray 350 IoversolNon Ioniclow osmolarMallinckrodt 8 ml6 ml40 ml45 ml45 ml9 ml45 ml60 ml40 ml9.0 * Optiray 350: 9.0 cPs (Cardiac Angiography)
Oxilan 300 IoxilanNon Ioniclow osmolarGuerbet8-12 ml         5.1 * Cerebral Arteriography
Oxilan 350 IoxilanNon Ioniclow osmolarGuerbet 2-10 ml2-10 ml25-50 ml45-100 ml    10-40 ml8.1 * Coronary Arteriography and Left Ventriculography, Visceral Angiography, Aortography, and Peripheral Arteriography
Ultravist 150 IopromideNon Ioniclow osmolarBayer HealthCare6-10 mlNot 4 ♥.Not 4 ♥.Not 4 ♥.20-50 ml2-20 ml    1.5 * Intra-Arterial Digital Subtraction Angiography (IA-DSA)
Ultravist 240 IopromideNon Ioniclow osmolarBayer HealthCare Not 4 ♥.Not 4 ♥.Not 4 ♥.     5-40 ml2.8 * Ultravist 240 mg I/mL: 2.8 cPs (Peripheral Venography)
Ultravist 300 IopromideNon Ioniclow osmolarBayer HealthCare3-12 mlNot 4 ♥.Not 4 ♥.Not 4 ♥.     5-40 ml4.9 * Cerebral Arteriography and Peripheral Arteriography * Excretory Urography
Ultravist 370 IopromideNon Ioniclow osmolarBayer HealthCare 3-14 ml3-14 ml30-60 ml20-50 ml     102.3 hrs* Coronary Arteriography and Left Ventriculography, Visceral Angiography, and Aortography * Ultravist 370 mg l/mL: 10.0 cPs (Cardiac Angiography)
Vispaque 270 IodixanolNon Ioniclow osmolarGE Healthcare Not 4 ♥.Not 4 ♥.Not 4 ♥.20-50 ml5-30 ml10-25 ml5-30 ml  6.3 Vispaque 270: 6.3 cPs Intra-Arterial Digital Subtraction Angiography (IA-DSA)
Vispaque 320 IodixanolNon Ioniclow osmolarGE Healthcare10-14 ml3-10 ml3-8 ml20-45 ml30-70 ml 8-18 ml10-70 ml 20-90 ml11.82.1 hrsVispaque 320: 11.8 cPs (Cerebral, Peripheral, Cardiac, Visceral)


© 2018 Technowood America Corporation. All rights reserved. Privacy Act | Contact Us